The role of interleukin-1β in the pentylenetetrazole-induced kindling of seizures, in the rat hippocampus.
暂无分享,去创建一个
[1] E. Aronica,et al. Epilepsy and brain inflammation , 2013, Experimental Neurology.
[2] E. Aronica,et al. Blood plasma inflammation markers during epileptogenesis in post–status epilepticus rat model for temporal lobe epilepsy , 2013, Epilepsia.
[3] M. Morganti-Kossmann,et al. The Role of Markers of Inflammation in Traumatic Brain Injury , 2013, Front. Neurol..
[4] Orrin Devinsky,et al. Glia and epilepsy: excitability and inflammation , 2013, Trends in Neurosciences.
[5] H. Nahrevanian,et al. Intra-hippocampal injection of lipopolysaccharide inhibits kindled seizures and retards kindling rate in adult rats , 2013, Experimental Brain Research.
[6] M. de Curtis,et al. Seizure‐induced brain‐borne inflammation sustains seizure recurrence and blood–brain barrier damage , 2012, Annals of neurology.
[7] A. Dhir. Pentylenetetrazol (PTZ) Kindling Model of Epilepsy , 2012, Current protocols in neuroscience.
[8] A. Vezzani,et al. Brain inflammation as a biomarker in epilepsy. , 2011, Biomarkers in medicine.
[9] T. Shimazu,et al. Interleukin-1β causes long-term potentiation deficiency in a mouse model of septic encephalopathy , 2011, Neuroscience.
[10] J. B. Kempton,et al. Simultaneous measurement of multiple ear proteins with multiplex ELISA assays , 2011, Hearing Research.
[11] G. Juhász,et al. The effect of intraperitoneally administered dimethyl sulfoxide on absence-like epileptic activity of freely moving WAG/Rij rats , 2011, Journal of Neuroscience Methods.
[12] M. Lehner,et al. The effect of CRF2 receptor antagonists on rat conditioned fear responses and c-Fos and CRF expression in the brain limbic structures , 2011, Behavioural Brain Research.
[13] D. Abdallah. Anticonvulsant potential of the peroxisome proliferator-activated receptor gamma agonist pioglitazone in pentylenetetrazole-induced acute seizures and kindling in mice , 2010, Brain Research.
[14] R. Sankar,et al. Inflammation induced by LPS enhances epileptogenesis in immature rat and may be partially reversed by IL1RA , 2010, Epilepsia.
[15] M. Schultzberg,et al. Connection between inflammatory processes and transmittor function—Modulatory effects of interleukin-1 , 2010, Progress in Neurobiology.
[16] F. Crews,et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration , 2007, Glia.
[17] A. Vezzani,et al. Status epilepticus induces time-dependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system , 2006, Neuroscience.
[18] E. Aronica,et al. The IL-1β system in epilepsy-associated malformations of cortical development , 2006, Neurobiology of Disease.
[19] C. Gurses,et al. Effects of lipopolysaccharide on blood-brain barrier permeability during pentylenetetrazole-induced epileptic seizures in rats. , 2006, Life sciences.
[20] Z. Herman,et al. Effect of chronic treatment with perazine on lipopolysaccharide-induced interleukin-1β levels in the rat brain , 2006, Naunyn-Schmiedeberg's Archives of Pharmacology.
[21] E. O’Hare,et al. Chronic intracerebroventricular infusion of lipopolysaccharide: effects of ibuprofen treatment and behavioural and histopathological correlates , 2005, Behavioural pharmacology.
[22] M. Plotkine,et al. Characterization of a rat model to study acute neuroinflammation on histopathological, biochemical and functional outcomes , 2005, Journal of Neuroscience Methods.
[23] A. Vezzani,et al. Tumor necrosis factor‐α inhibits seizures in mice via p75 receptors , 2005 .
[24] M. Shokrgozar,et al. Antiepileptogenic and anticonvulsant activity of interleukin-1β in amygdala-kindled rats , 2005, Experimental Neurology.
[25] Britta Schöning,et al. Brain-IL-1 beta triggers astrogliosis through induction of IL-6: inhibition by propranolol and IL-10. , 2004, Medical science monitor : international medical journal of experimental and clinical research.
[26] M. Lynch,et al. Lipopolysaccharide‐induced increase in signalling in hippocampus is abrogated by IL‐10 – a role for IL‐1β? , 2004, Journal of neurochemistry.
[27] P. Spano,et al. Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices , 2004, Molecular and Cellular Neuroscience.
[28] M. Sayyah,et al. The bacterial endotoxin lipopolysaccharide enhances seizure susceptibility in mice: involvement of proinflammatory factors: nitric oxide and prostaglandins , 2003, Neuroscience.
[29] S. Allan,et al. Interleukin‐1 in the Brain , 2003 .
[30] C. Woiciechowsky,et al. Differences in immune cell invasion into the cerebrospinal fluid and brain parenchyma during cerebral infusion of interleukin-1β , 2002, Neurological Sciences.
[31] Asla Pitkänen,et al. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy , 2002, The Lancet Neurology.
[32] A. Vezzani,et al. Functional Role of Inflammatory Cytokines and Antiinflammatory Molecules in Seizures and Epileptogenesis , 2002, Epilepsia.
[33] L. S. Godlevsky,et al. The role of TNF-α in amygdala kindled rats , 2002, Neuroscience Research.
[34] C. Plata-salamán,et al. Pro-inflammatory and anti-inflammatory cytokine mRNA induction in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide , 2001, Brain Research Bulletin.
[35] W. Friedman. Cytokines Regulate Expression of the Type 1 Interleukin-1 Receptor in Rat Hippocampal Neurons and Glia , 2001, Experimental Neurology.
[36] S. Garattini,et al. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus , 2000, The European journal of neuroscience.
[37] M. Hennerici,et al. Temporal profile of release of interleukin-1β in neurotrauma , 2000, Neuroscience Letters.
[38] C. Plata-salamán,et al. Kindling modulates the IL-1β system, TNF-α, TGF-β1, and neuropeptide mRNAs in specific brain regions , 2000 .
[39] C. Woiciechowsky,et al. Continuous infusion of proinflammatory cytokines into the brain to study brain cytokine induced local and systemic immune effects. , 1999, Brain research. Brain research protocols.
[40] A. Vezzani,et al. Interleukin-1β Immunoreactivity and Microglia Are Enhanced in the Rat Hippocampus by Focal Kainate Application: Functional Evidence for Enhancement of Electrographic Seizures , 1999, The Journal of Neuroscience.
[41] G. Rondouin,et al. Release of TNFα in the rat hippocampus following epileptic seizures and excitotoxic neuronal damage , 1996, Neuroreport.
[42] N. Rothwell,et al. Cytokines in neurodegeneration and repair , 1995, International Journal of Developmental Neuroscience.
[43] N. Rothwell,et al. Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[44] M. Gayle,et al. Interleukin 1 signaling occurs exclusively via the type I receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[45] G. Fillion,et al. Receptors for interleukin-1 (α and β) in mouse brain: Mapping and neuronal localization in hippocampus , 1991, Neuroscience.
[46] Takashi Yamaguchi,et al. Convulsants induce interleukin-1β messenger RNA in rat brain , 1990 .
[47] R. Racine,et al. Epileptiform activity and neural plasticity in limbic structures. , 1972, Brain research.
[48] E. Pinteaux,et al. Cell-specific and concentration-dependent actions of interleukin-1 in acute brain inflammation. , 2009, Cytokine.